The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly. 2009

M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

OBJECTIVE The aim of the study was to evaluate the impact of the genomic deletion of exon 3 of the GH receptor (d3GHR) on long-term clinical outcome of acromegaly in a well-characterized cohort of patients with long-term remission of acromegaly. METHODS We conducted a cross-sectional study. METHODS The presence of the d3GHR polymorphism was assessed in 86 acromegalic patients with long-term disease control and related to anthropometric parameters, cardiovascular risk factors, osteoarthritis, bone mineral density, colonic polyps and diverticulae, and dolichocolon. RESULTS Fifty-one patients had two wild-type alleles (59%), whereas 29 patients (34%) had one allele and six patients (7%) had two alleles encoding for the d3GHR isoform. Carriers of the d3GHR isoform showed increased prevalence of osteoarthritis, especially of the hip [adjusted odds ratio (OR), 5.2; 95% confidence interval (CI), 3.2-7.1], of adenomatous polyps (adjusted OR, 4.1; 95% CI, 2.4-5.6), and dolichocolon (adjusted OR, 3.2; 95% CI, 1.8-4.6). Anthropometric parameters, cardiovascular risk factors, bone mineral density, and (non)vertebral fractures were not significantly different between patients with and without the d3GHR allele. CONCLUSIONS In patients with long-term cured acromegaly, the d3GHR polymorphism is associated with an increased prevalence of irreversible comorbidities such as osteoarthritis, dolichocolon, and adenomatous colonic polyps, but not with other comorbidities such as cardiovascular risk factors.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D011986 Receptors, Somatotropin Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. Growth Hormone Receptors,Receptors, Growth Hormone,Somatomammotropin Receptors,Somatotropin Receptors,Growth Hormone Receptor,Receptor, Growth Hormone,Receptors, Somatomammotropin,Somatomammotropin Receptor,Somatotropin Receptor,Hormone Receptor, Growth,Hormone Receptors, Growth
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003108 Colonic Diseases Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE). Colonic Disease,Disease, Colonic,Diseases, Colonic

Related Publications

M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
January 2010, The Journal of clinical endocrinology and metabolism,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
January 2011, Journal of clinical research in pediatric endocrinology,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
November 2017, Saudi medical journal,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
June 2015, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
January 2014, Research in pharmaceutical sciences,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
February 2014, Annals of the rheumatic diseases,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
September 2023, International journal of molecular sciences,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
January 2017, Neuroendocrinology,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
January 2012, Hormone research in paediatrics,
M J E Wassenaar, and N R Biermasz, and A M Pereira, and A A van der Klaauw, and J W A Smit, and F Roelfsema, and T van der Straaten, and M Cazemier, and D W Hommes, and H M Kroon, and M Kloppenburg, and H-J Guchelaar, and J A Romijn
September 2015, Endocrinology and metabolism (Seoul, Korea),
Copied contents to your clipboard!